Browse All

Current Filters

CLEAR FILTER x

TITLE

Protocol to Help Neurologists Manage Subcutaneous Apomorphine Therapy Skin Nodules: Expert Roundtable Recommendations

Author:Isaacson, Stuart   Grall, Mindy   Gupta, Fiona   Kremens, Daniel   Nguyen, Cuong   Pahwa, Rajesh   Serota, Marc   Zirwas, Matthew   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.023  

Author Institution:

Pharmacokinetic-pharmacodynamic Modeling of Amantadine Extended-release Capsule Effects on Dyskinesia in Parkinson Disease

Author:Wang, Zhao   Gomeni, Roberto   Pahwa, Rajesh   Hauser, Robert   Formella, Andrea   Grall, Mindy   Upadhyaya, Himanshu   Rubin, Jonathan   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.028  

Author Institution:

Improvement in Uninterrupted Good ON Time and Reduction in OFF Periods with CSAI Treatment

Author:Kremens, Daniel   Hauser, Robert   Formella, Andrea   Joshi, Milan   Grall, Mindy   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.028  

Author Institution:University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, FL  

Patient Experiences Initiating Continuous Subcutaneous Apomorphine Infusion (CSAI): An Interview-based Survey of InfusON Study Participants

Author:Agarwal, Pinky   Crouse, Nikkilina   Breiteneicher, Arianne   Grall, Mindy   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.029  

Author Institution:Evergreen Health, Kirkland, WA  Supernus Pharmaceuticals, Inc, Rockville, MD  Supernus Pharmaceuticals, Chicago, IL